Home > Node > Subnode Bosentan Taéron, C. Revue de l'Infirmiere 2005(108): 33-342005ISSN/ISBN: 1293-8505 PMID: 15816717 Document Number: 586940 Document emailed within 1 workday Purchase for $29.90 Secure & encrypted paymentsRelated DocumentsCasellas, D.; Bouriquet, N.; Herizi, A. 1997: Bosentan prevents preglomerular alterations during angiotensin II hypertension Hypertension 30(6): 1613-1620Durongpisitkul, K.; Jakrapanichakul, D.; Sompradikul, S. 2008: A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease Journal of the Medical Association of Thailand 91(2): 196-202Roldan, R.; Morote, G.; Castro, M.d.C.; Miranda, M.D.; Moreno, J.C.; Collantes, E. 2006: Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children Journal of Rheumatology 33(12): 2538-2540Zhang, C.-Y.; Zhang, N.; He, L. 2014: Quantitative determination of bosentan by proton nuclear magnetic resonance with internal standard method Yao Xue Xue Bao 49(2): 249-251